Literature DB >> 7798636

No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.

R Wienecke1, E M Schlüpen, N Zöchling, U Neubert, M Meurer, M Volkenandt.   

Abstract

A possible association of Borrelia burgdorferi with localized scleroderma is currently the focus of intense research and discussion. Skin biopsies from 30 patients with localized scleroderma (28 of the plaque type/morphea; two linear scleroderma) were analyzed for the presence of Borrelia burgdorferi using three different polymerase chain reaction systems for amplification of segments of borrelial genes. Formalin-fixed, paraffin-embedded biopsies of 14 patients and fresh-frozen, cryo-conserved biopsies of 16 patients with localized scleroderma were obtained. Lesions of all patients showed clear signs of scleroderma and disease progression at the time of biopsy. Fresh-frozen as well as formalin-fixed biopsies from patients with erythema migrans or acrodermatitis chronica atrophicans were used as positive controls. With all three polymerase chain reaction systems, borrelial DNA was detected in none of the 30 specimens of localized scleroderma. In contrast, with one polymerase chain reaction system, Borrelia burgdorferi-specific DNA was found in 24 of 27 frozen biopsies from patients with erythema migrans and in all 5 analyzed frozen biopsies of patients with acrodermatitis chronica atrophicans. In approximately half of the paraffin-embedded biopsies from patients with erythema migrans (nine of 23) and acrodermatitis chronica atrophicans (13 of 27), Borrelia burgdorferi-specific DNA was identified. These results question the association of localized scleroderma with known subtypes of Borrelia burgdorferi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798636     DOI: 10.1111/1523-1747.ep12613456

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR.

Authors:  S Mommert; R Gutzmer; A Kapp; T Werfel
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.

Authors:  J R Goodlad; M M Davidson; P Gordon; R Billington; D O Ho-Yen
Journal:  Mol Pathol       Date:  2002-12

Review 3.  PCR in laboratory diagnosis of human Borrelia burgdorferi infections.

Authors:  B L Schmidt
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 5.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

6.  Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR.

Authors:  F B Cogswell; C E Bantar; T G Hughes; Y Gu; M T Philipp
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.

Authors:  S Brettschneider; H Bruckbauer; N Klugbauer; H Hofmann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Frequency of Borrelia in Morphea Lesion by Polymerase Chain Reaction in Northeast of Iran.

Authors:  Mohhamad Javad Yazdanpanah; Norieh Sharifi; Alireza Khooei; Mahnaz Banihashemi; Mohammad Khaje-Daluee; Azadeh Shamsi; Kiarash Ghazvini
Journal:  Jundishapur J Microbiol       Date:  2015-08-27       Impact factor: 0.747

Review 9.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.